Overview

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
To compare the relative efficacy for calcium pre-treatment in decreasing incidence of drug induced hypotension after diltiazem administration for treatment of AFF with RVR. Null Hypothesis: There will be no difference between groups in incidence of hypotension after pretreatment with calcium prior to bolus of diltiazem.
Phase:
Phase 4
Details
Lead Sponsor:
Aurora Health Care
Treatments:
Calcium